IBANDRONATE

作品数：14被引量：9H指数：2
导出分析报告
相关领域：医药卫生更多>>
相关机构：浙江大学医学院附属第一医院更多>>
相关期刊：《World Journal of Gastroenterology》《中国新药杂志》《Surgical Science》《Chinese Medical Journal》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Postmenopausal Osteoporosis and Osteopenia Management with a Combination of Once-Monthly Oral Ibandronate and Cholecalciferol—A Systematic Review
《International Journal of Clinical Medicine》2023年第1期34-57,共24页Mauro Geller Mendel Suchmacher Marcio Cohen Spyros G. E. Mezitis Flavia Wajnsztajn-Theil Karin G. Cunha Rafael Nigri 
Postmenopausal osteoporosis and osteopenia are chronic and uncurable conditions that invariably lead to an increased risk of vertebral, hip, and femoral neck fracture if left untreated. Clinical guidelines establish, ...
关键词：IBANDRONATE CHOLECALCIFEROL Postmenopausal Osteoporosis Postmenopausal Osteopenia Systematic Review 
Prevalence of Non-Responders to Both Oral Bisphosphonate Monotherapy and Intravenous Ibandronate in Patients with Postmenopausal Osteoporosis
《Open Journal of Orthopedics》2020年第3期43-53,共11页Naohisa Miyakoshi Yuji Kasukawa Michio Hongo Akira Horikawa Yoichi Shimada 
Objectives: Although bisphosphonates (BPs) are effective for the majority of patients with osteoporosis, some individuals do not adequately respond to these drugs. The objective of this study was to estimate the preva...
关键词：Bone RESORPTION Biphosphonates Ibandronic Acid Osteoporosis PREVALENCE 
Online Postcolumn Indirect Detection for Determination of Ibandronate in Pharmaceutical Tablets by HPLC/DAD
《Journal of Analysis and Testing》2019年第4期322-330,共9页Mokhtar Mabrouk Sherin F.Hammad Mohamed A.Abdelaziz Fotouh R.Mansour 
Ibandronate sodium monohydrate is a highly polar aliphatic compound that belongs to the bisphosphonate class,a widely used bone resorption inhibitor.The aliphatic nature of ibandronate precludes direct photometric det...
关键词：BISPHOSPHONATES Non-chromophoric drugs Highly polar compounds High-performance liquid chromatography Reversed phase 
A candidate identification questionnaire for postmenopausal osteoporosis patients switched from daily or weekly bisphosphonate to once-monthly ibandronate: An open, prospective, multicenter study—BONCURE study
《Health》2013年第7期30-40,共11页Yesim Gokce Kutsal Nurten Eskiyurt Jale Irdesel Vesile Sepici Hatice Ugurlu Yesim Kirazli Fusun Ardic Mirko Korsic Tonko Vlak Mane Grlickov Snezana Markovic Temelkova Miroslav Lazarov Nada Pilipovic Vera Popovic Aleksandar Dimic Branka Kovacev 
A candidate identification questionnaire (CIQ) was tested to determine its predictive value for patient-reported satisfaction in patients switched from once-weekly or once-daily treatment with a bisphosphonate to once...
关键词：BISPHOSPHONATE Compliance IBANDRONATE POSTMENOPAUSAL Osteoporosis 
In vitro osteoclast-suppressing effect of sodium ibandronate被引量：1
《Chinese Medical Journal》2013年第4期751-755,共5页ZHANG Wei YANG Da-long WANG Ytm-xia WANG Hui-wang ZHEN Zeng-jiang ZHANG Ying-ze SHEN Yong 
Background Bisphosphonates （BPs） have been reported to reduce local recurrence in giant cell tumor （GCT） of bone because of their osteoclast-suppressing effect; however, the optimal mode of delivery and the dose a...
关键词：giant cell tumor OSTEOCLAST IBANDRONATE bisphosphonate. 
Chugai Pharmaceutical公司提交了ibandronate sodium hydrate的新药申请
《中国新药杂志》2012年第19期2218-2218,共1页
Taisho Pharmaceutical公司的合作伙伴Chugai Pharmaceutical公司向日本厚生劳动省提交了ibandronate sodium hydrate（RG-484；CT-064）的新药申请（NDA）。本品是Taisho Pharmaceutica忪司和Chugai Pharmaceutical公司联合开发的一种...
关键词：IBANDRONATE 新药申请 骨吸收抑制剂 合作伙伴 注射制剂 二膦酸盐 
骨质疏松药Boniva(ibandronate)专利到期首批仿制药获准上市
《广东药学院学报》2012年第2期148-148,共1页夏训明 
Boniva（ibandronate,伊班膦酸钠）是一种二膦酸盐类药物,是罗氏公司研制生产的骨质疏松药,该药的专利保护已经到期。美国FDA于2012年3月19日批准首批该药的仿制药上市,剂型为150 mg片剂,1个月服用1次,
关键词：骨质疏松药 专利保护 仿制药 上市 二膦酸盐类药物 伊班膦酸钠 美国FDA 罗氏公司 
Prevention of Femoral Head Deformity after Ischemic Necrosis Using Ibandronate Acid and Growth Factor in Immature Pigs被引量：4
《Surgical Science》2012年第4期194-199,共6页Bibiana Dello Russo Eduardo Luis Baroni Nicolas Saravia Valeria Amelong Fabiana Lubiniecky Marcelo Asprea Gustavo Williams Susana Rodriguez 
Background: Femoral head deformity is the most severe sequela of ischemic necrosis in skeletally immature patients. Development of severe deformity shortens useful survival time of the joint due to the appearance of e...
关键词：Perthe’s Disease AVASCULAR Necrosis IBANDRONATE ACID Platelet-Rich Plasma 
Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta被引量：4
《Chinese Medical Journal》2011年第19期3049-3053,共5页LI Mei XIA Wei-bo XING Xiao-ping YU Wei HU Ying-ying JIANG Yan WANG Ou LIU Hai-juan HAN Lan-wen MENG Xun-wu XU Ling 
Background Osteogenesis imperfecta （OI） is a rare bone disease and its effective treatment is relatively deficient. We tried to assess the effects of new bisphosphonate, ibandronate on children with OI.Methods In th...
关键词：osteogenesis imperfecta IBANDRONATE annual new fracture rate bone mineral density 
Bones and Crohn’s:No benefit of adding sodium fluoride or ibandronate to calcium and vitamin D
《World Journal of Gastroenterology》2011年第3期334-342,共9页Jochen Klaus Max Reinshagen Katharina Herdt Christoph Schrter Guido Adler Georg BT von Boyen Christian von Tirpitz 
AIM: To compare the effect of calcium and cholecalciferol alone and along with additional sodium fluoride or ibandronate on bone mineral density (BMD) and fractures in patients with Crohn's disease (CD). METHODS: Pati...
关键词：Crohn’s disease Bone mineral density Vertebral fracture CHOLECALCIFEROL CALCIUM IBANDRONATE Sodium fluoride 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部